ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,328Medicare Part D Prescriptions Filled, Including Refills

Rank: 111 out of 1107

$766K Total Retail Price of All Prescriptions

Rank: 180 out of 1107

796 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 796 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 796 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 12,799 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 706 522 1 2
SIMVASTATIN 549 447 2 5
METFORMIN HCL 539 370 3 8
LEVOTHYROXINE SODIUM 528 430 4 3
OMEPRAZOLE 518 331 5 4
PRAVASTATIN SODIUM 454 369 6 12
HYDROCODONE-ACETAMINOPHEN 429 253 S3 7 1
AMLODIPINE BESYLATE 410 316 8 6
METOPROLOL TARTRATE 365 273 9 10
MELOXICAM 334 257 10 25
FUROSEMIDE 323 264 11 7
CITALOPRAM HBR 309 198 12 17
HYDROCHLOROTHIAZIDE 295 224 13 11
ATORVASTATIN CALCIUM 243 177 14 13
NEXIUM 242 166 15 18
WARFARIN SODIUM 236 198 16 15
POTASSIUM CHLORIDE 212 158 17 14
SERTRALINE HCL 184 145 18 20
CLOPIDOGREL 181 139 19 28
GABAPENTIN 177 121 20 9
GLIPIZIDE ER 174 145 21 115
AZITHROMYCIN 173 110 22 35
ZOLPIDEM TARTRATE 167 149 23 22
RANITIDINE HCL 163 113 24 21
ATENOLOL 161 140 25 19
AMOXICILLIN 161 109 25 90
TRAMADOL HCL 144 114 27 26
GLIPIZIDE XL 141 90 28 166
CARVEDILOL 137 118 29 27
GLIPIZIDE 134 61 30 64
METOPROLOL SUCCINATE 128 116 31 16
PLAVIX 128 96 31 39
DONEPEZIL HCL 126 126 33 32
DICLOFENAC SODIUM 123 108 34 74
CRESTOR 121 80 35 23
ISOSORBIDE MONONITRATE ER 121 98 35 34
LANTUS 119 67 37 49
ZETIA 111 75 38 76
LANSOPRAZOLE 101 86 39 102
LIPITOR 99 86 40 109
GEMFIBROZIL 95 45 41 107
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 67 42 24
AMITRIPTYLINE HCL 91 66 R 43 48
LOVASTATIN 90 59 44 55
CLONIDINE HCL 89 46 45 53
DOXAZOSIN MESYLATE 86 70 46 92
METHOCARBAMOL 84 66 R 47 142
CIPROFLOXACIN HCL 83 61 48 59
GLYBURIDE 83 59 R 48 68
LOSARTAN POTASSIUM 81 55 50 29
SYNTHROID 78 52 51 70
DIGOXIN 77 64 52 52
INSULIN SYRINGE 77 51 52 78
NAMENDA 75 75 54 42
POLYETHYLENE GLYCOL 3350 73 62 55 46
PREDNISONE 71 65 56 40
FAMOTIDINE 70 34 57 111
METOCLOPRAMIDE HCL 70 58 57 116
BUMETANIDE 69 69 59 123
GLIMEPIRIDE 69 59 59 43
BUSPIRONE HCL 69 46 59 107
NIFEDIPINE ER 68 61 62 168
TRIAMTERENE-HCTZ 64 53 63 62
PROMETHAZINE HCL 62 48 R 64 44
ENALAPRIL MALEATE 61 50 65 98
MECLIZINE HCL 61 40 65 114
CEPHALEXIN 60 36 67 81
CELEBREX 59 30 68 85
TRAMADOL HCL-ACETAMINOPHEN 57 33 69 195
ETODOLAC 56 38 70 210
ACTOS 56 29 70 132
BYSTOLIC 56 54 70 138
TRICOR 56 29 70 95
DILTIAZEM HCL 56 40 70 239
ACETAMINOPHEN-CODEINE 54 53 S3 75 120
IBUPROFEN 54 25 75 63
ACARBOSE 53 47 77 297
ALLOPURINOL 52 38 78 36
LORAZEPAM 52 41 78 155
SPIRONOLACTONE 52 36 78 72
KLOR-CON M10 52 51 78 159
TRIAMCINOLONE ACETONIDE 51 30 82 137
TAMSULOSIN HCL 51 41 82 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.